Approaches for designing synthetic, low molecular weight inhibitors of clotting enzymes.
D000818:Animals; D000925:Anticoagulants; D001665:Binding Sites; D001777:Blood Coagulation; D005170:Factor X / Q000037:antagonists & inhibitors; D015951:Factor Xa; D005343:Fibrinolytic Agents; D006801:Humans; D008970:Molecular Weight; D011480:Protease Inhibitors / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D011480:Protease Inhibitors; D005170:Factor X; D013917:Thrombin; D015951:Factor Xa